« Previous
Next »
Annals of Emergency Medicine
Volume 52, Issue 1
, Pages 22-29.e6
, July 2008
The Role of Oral Ondansetron in Children With Vomiting as a Result of Acute Gastritis/Gastroenteritis Who Have Failed Oral Rehydration Therapy: A Randomized Controlled Trial
References
- . Practice parameter: the management of acute gastroenteritis in young children (American Academy of Pediatrics. Provisional Committee on Quality Improvement, Subcommittee on Acute Gastroenteritis). Pediatrics. 1996;97:424–435
- . Prochlorperazine versus promethazine for uncomplicated nausea and vomiting in the emergency department: a randomized, double-blind clinical trial. Ann Emerg Med. 2000;36:89–94
- . Promethazine-induced dystonic reaction. Pediatr Emerg Care. 1987;3:91–92
- . Toxic effects of metoclopramide. Pediatr Rev. 1992;13:117
- Phenergan (promethazine HCl). Madison, NJ: Wyeth Pharmaceuticals, Inc; 2004;[package insert]
- Antiemetic activity of ondansetron in acute gastroenteritis. Aliment Pharmacol Ther. 1997;11:185–191
- . Ondansetron decreases vomiting associated with acute gastroenteritis: a randomized, controlled trial. Pediatrics. 2002;109:e62
- A randomized clinical trial comparing oral ondansetron with placebo in children with vomiting from acute gastroenteritis. Ann Emerg Med. 2002;39:397–403
- Oral ondansetron for gastroenteritis in a pediatric emergency department. N Engl J Med. 2006;354:1698–1705
Reprints not available from the authors.
Author contributions: TSH and KKM conceived the study and designed the trial. KKM supervised the conduct of the trial and data collection and managed the data. GR, TSH, and KKM enrolled subjects and guided other physicians in the department as they enrolled patients. KKM provided statistical advice on study design and analyzed the data. GR and KKM drafted the article, and TSH contributed substantially to its revision. GR takes responsibility for the paper as a whole.
Supervising editor: David M. Jaffe, MD
Funding and support: By Annals policy, all authors are required to disclose any and all commercial, financial, and other relationships in any way related to the subject of this article, that might create any potential conflict of interest. See the Manuscript Submission Agreement in this issue for examples of specific conflicts covered by this statement. GlaxoSmithKline supplied placebo tablets but no other financial or in-kind support for this study.
The authors were previously affiliated with the Department of Emergency Medicine, Advocate Christ Medical Center, Oak Lawn, IL.
Publication dates: Available online November 19, 2007.
PII: S0196-0644(07)01546-6
doi: 10.1016/j.annemergmed.2007.09.010
© 2008 American College of Emergency Physicians. Published by Elsevier Inc. All rights reserved.
« Previous
Next »
Annals of Emergency Medicine
Volume 52, Issue 1
, Pages 22-29.e6
, July 2008
